The DeSci Podcast  cover image

How We Can Do Better Drug Discovery | Jack Scannell

The DeSci Podcast

CHAPTER

I Think the Real Risk in Drug R&D Has Shifted From Chemistry Risk to Decision Tool Risk

I've done some work with emulate and there's a paper on bio archive which I hope will be coming out fairly soon which summarizes that work. Emulate or accompany the make organ ships they were spun out of Harvard by Dawn Inber and organ ships were attempt to solve a problem that is evident from cell cultures. If you culture human cells pretty soon they stop behaving like human liver cells right so sure they were once part of a human liver but they expect them to behave like human liver anymore. There's no really good financial frameworks for working out how much better predictive power is worth because the people using drug and biotech valuation are blind to decision quality Right now emulate decided to have a close look at

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner